This report contains market size and forecasts of Bioburden Testing in Global, including the following market information:
Global Bioburden Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Bioburden Testing market was valued at 571.8 million in 2020 and is projected to reach US$ 741.9 million by 2027, at a CAGR of 6.7% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bioburden Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bioburden Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Bioburden Testing Market Segment Percentages, By Type, 2020 (%)
Instruments
Consumables
China Bioburden Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Bioburden Testing Market Segment Percentages, By Application, 2020 (%)
Pharmaceutical
Biotechnology
Global Bioburden Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Bioburden Testing Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Bioburden Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Bioburden Testing Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Charles River Laboratories International
Sigma-Aldrich
SGS
Wuxi Pharmatech (CAYMAN)
Merck
Becton Dickinson
North American Science Associates Inc.
Nelson Laboratories
Pacific Biolabs
ATS Labs
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Bioburden Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bioburden Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bioburden Testing Overall Market Size
2.1 Global Bioburden Testing Market Size: 2021 VS 2027
2.2 Global Bioburden Testing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bioburden Testing Players in Global Market
3.2 Top Global Bioburden Testing Companies Ranked by Revenue
3.3 Global Bioburden Testing Revenue by Companies
3.4 Top 3 and Top 5 Bioburden Testing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Bioburden Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bioburden Testing Players in Global Market
3.6.1 List of Global Tier 1 Bioburden Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Bioburden Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bioburden Testing Market Size Markets, 2021 & 2027
4.1.2 Instruments
4.1.3 Consumables
4.2 By Type - Global Bioburden Testing Revenue & Forecasts
4.2.1 By Type - Global Bioburden Testing Revenue, 2016-2021
4.2.2 By Type - Global Bioburden Testing Revenue, 2022-2027
4.2.3 By Type - Global Bioburden Testing Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bioburden Testing Market Size, 2021 & 2027
5.1.2 Pharmaceutical
5.1.3 Biotechnology
5.2 By Application - Global Bioburden Testing Revenue & Forecasts
5.2.1 By Application - Global Bioburden Testing Revenue, 2016-2021
5.2.2 By Application - Global Bioburden Testing Revenue, 2022-2027
5.2.3 By Application - Global Bioburden Testing Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Bioburden Testing Market Size, 2021 & 2027
6.2 By Region - Global Bioburden Testing Revenue & Forecasts
6.2.1 By Region - Global Bioburden Testing Revenue, 2016-2021
6.2.2 By Region - Global Bioburden Testing Revenue, 2022-2027
6.2.3 By Region - Global Bioburden Testing Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Bioburden Testing Revenue, 2016-2027
6.3.2 US Bioburden Testing Market Size, 2016-2027
6.3.3 Canada Bioburden Testing Market Size, 2016-2027
6.3.4 Mexico Bioburden Testing Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Bioburden Testing Revenue, 2016-2027
6.4.2 Germany Bioburden Testing Market Size, 2016-2027
6.4.3 France Bioburden Testing Market Size, 2016-2027
6.4.4 U.K. Bioburden Testing Market Size, 2016-2027
6.4.5 Italy Bioburden Testing Market Size, 2016-2027
6.4.6 Russia Bioburden Testing Market Size, 2016-2027
6.4.7 Nordic Countries Bioburden Testing Market Size, 2016-2027
6.4.8 Benelux Bioburden Testing Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Bioburden Testing Revenue, 2016-2027
6.5.2 China Bioburden Testing Market Size, 2016-2027
6.5.3 Japan Bioburden Testing Market Size, 2016-2027
6.5.4 South Korea Bioburden Testing Market Size, 2016-2027
6.5.5 Southeast Asia Bioburden Testing Market Size, 2016-2027
6.5.6 India Bioburden Testing Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Bioburden Testing Revenue, 2016-2027
6.6.2 Brazil Bioburden Testing Market Size, 2016-2027
6.6.3 Argentina Bioburden Testing Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bioburden Testing Revenue, 2016-2027
6.7.2 Turkey Bioburden Testing Market Size, 2016-2027
6.7.3 Israel Bioburden Testing Market Size, 2016-2027
6.7.4 Saudi Arabia Bioburden Testing Market Size, 2016-2027
6.7.5 UAE Bioburden Testing Market Size, 2016-2027
7 Players Profiles
7.1 Charles River Laboratories International
7.1.1 Charles River Laboratories International Corporate Summary
7.1.2 Charles River Laboratories International Business Overview
7.1.3 Charles River Laboratories International Bioburden Testing Major Product Offerings
7.1.4 Charles River Laboratories International Bioburden Testing Revenue in Global (2016-2021)
7.1.5 Charles River Laboratories International Key News
7.2 Sigma-Aldrich
7.2.1 Sigma-Aldrich Corporate Summary
7.2.2 Sigma-Aldrich Business Overview
7.2.3 Sigma-Aldrich Bioburden Testing Major Product Offerings
7.2.4 Sigma-Aldrich Bioburden Testing Revenue in Global (2016-2021)
7.2.5 Sigma-Aldrich Key News
7.3 SGS
7.3.1 SGS Corporate Summary
7.3.2 SGS Business Overview
7.3.3 SGS Bioburden Testing Major Product Offerings
7.3.4 SGS Bioburden Testing Revenue in Global (2016-2021)
7.3.5 SGS Key News
7.4 Wuxi Pharmatech (CAYMAN)
7.4.1 Wuxi Pharmatech (CAYMAN) Corporate Summary
7.4.2 Wuxi Pharmatech (CAYMAN) Business Overview
7.4.3 Wuxi Pharmatech (CAYMAN) Bioburden Testing Major Product Offerings
7.4.4 Wuxi Pharmatech (CAYMAN) Bioburden Testing Revenue in Global (2016-2021)
7.4.5 Wuxi Pharmatech (CAYMAN) Key News
7.5 Merck
7.5.1 Merck Corporate Summary
7.5.2 Merck Business Overview
7.5.3 Merck Bioburden Testing Major Product Offerings
7.5.4 Merck Bioburden Testing Revenue in Global (2016-2021)
7.5.5 Merck Key News
7.6 Becton Dickinson
7.6.1 Becton Dickinson Corporate Summary
7.6.2 Becton Dickinson Business Overview
7.6.3 Becton Dickinson Bioburden Testing Major Product Offerings
7.6.4 Becton Dickinson Bioburden Testing Revenue in Global (2016-2021)
7.6.5 Becton Dickinson Key News
7.7 North American Science Associates Inc.
7.7.1 North American Science Associates Inc. Corporate Summary
7.7.2 North American Science Associates Inc. Business Overview
7.7.3 North American Science Associates Inc. Bioburden Testing Major Product Offerings
7.4.4 North American Science Associates Inc. Bioburden Testing Revenue in Global (2016-2021)
7.7.5 North American Science Associates Inc. Key News
7.8 Nelson Laboratories
7.8.1 Nelson Laboratories Corporate Summary
7.8.2 Nelson Laboratories Business Overview
7.8.3 Nelson Laboratories Bioburden Testing Major Product Offerings
7.8.4 Nelson Laboratories Bioburden Testing Revenue in Global (2016-2021)
7.8.5 Nelson Laboratories Key News
7.9 Pacific Biolabs
7.9.1 Pacific Biolabs Corporate Summary
7.9.2 Pacific Biolabs Business Overview
7.9.3 Pacific Biolabs Bioburden Testing Major Product Offerings
7.9.4 Pacific Biolabs Bioburden Testing Revenue in Global (2016-2021)
7.9.5 Pacific Biolabs Key News
7.10 ATS Labs
7.10.1 ATS Labs Corporate Summary
7.10.2 ATS Labs Business Overview
7.10.3 ATS Labs Bioburden Testing Major Product Offerings
7.10.4 ATS Labs Bioburden Testing Revenue in Global (2016-2021)
7.10.5 ATS Labs Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Bioburden Testing Market Opportunities & Trends in Global Market
Table 2. Bioburden Testing Market Drivers in Global Market
Table 3. Bioburden Testing Market Restraints in Global Market
Table 4. Key Players of Bioburden Testing in Global Market
Table 5. Top Bioburden Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Bioburden Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Bioburden Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Bioburden Testing Product Type
Table 9. List of Global Tier 1 Bioburden Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bioburden Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type